These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23365420)

  • 41. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses.
    Jamieson BD; Yang OO; Hultin L; Hausner MA; Hultin P; Matud J; Kunstman K; Killian S; Altman J; Kommander K; Korber B; Giorgi J; Wolinsky S
    J Immunol; 2003 Nov; 171(10):5372-9. PubMed ID: 14607940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.
    Mostowy R; Kouyos RD; Hoof I; Hinkley T; Haddad M; Whitcomb JM; Petropoulos CJ; Keşmir C; Bonhoeffer S
    PLoS Comput Biol; 2012; 8(5):e1002525. PubMed ID: 22654656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modelling the evolution and spread of HIV immune escape mutants.
    Fryer HR; Frater J; Duda A; Roberts MG; ; Phillips RE; McLean AR
    PLoS Pathog; 2010 Nov; 6(11):e1001196. PubMed ID: 21124991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis.
    Prince JL; Claiborne DT; Carlson JM; Schaefer M; Yu T; Lahki S; Prentice HA; Yue L; Vishwanathan SA; Kilembe W; Goepfert P; Price MA; Gilmour J; Mulenga J; Farmer P; Derdeyn CA; Tang J; Heckerman D; Kaslow RA; Allen SA; Hunter E
    PLoS Pathog; 2012; 8(11):e1003041. PubMed ID: 23209412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
    Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H
    J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV CTL escape: at what cost?
    Smith SM
    Retrovirology; 2004 May; 1():8. PubMed ID: 15169568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.
    Garcia-Bates TM; Palma ML; Anderko RR; Hsu DC; Ananworanich J; Korber BT; Gaiha GD; Phanuphak N; Thomas R; Tovanabutra S; Walker BD; Mellors JW; Piazza PA; Kroon E; Riddler SA; Michael NL; Rinaldo CR; Mailliard RB;
    EBioMedicine; 2021 Jan; 63():103175. PubMed ID: 33450518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies.
    Liu D; Wang C; Hora B; Zuo T; Goonetilleke N; Liu MKP; Berrong M; Ferrari G; McMichael AJ; Bhattacharya T; Perelson AS; Gao F
    Retrovirology; 2017 Oct; 14(1):46. PubMed ID: 29017536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia.
    Yang OO; Daar ES; Ng HL; Shih R; Jamieson BD
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):391-8. PubMed ID: 21087140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.
    Fernandez CS; Stratov I; De Rose R; Walsh K; Dale CJ; Smith MZ; Agy MB; Hu SL; Krebs K; Watkins DI; O'connor DH; Davenport MP; Kent SJ
    J Virol; 2005 May; 79(9):5721-31. PubMed ID: 15827187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.
    Ishii H; Kawada M; Tsukamoto T; Yamamoto H; Matsuoka S; Shiino T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Naruse TK; Kimura A; Takiguchi M; Matano T
    J Virol; 2012 Jan; 86(2):738-45. PubMed ID: 22072784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
    Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
    J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.
    Goepfert PA; Lumm W; Farmer P; Matthews P; Prendergast A; Carlson JM; Derdeyn CA; Tang J; Kaslow RA; Bansal A; Yusim K; Heckerman D; Mulenga J; Allen S; Goulder PJ; Hunter E
    J Exp Med; 2008 May; 205(5):1009-17. PubMed ID: 18426987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High frequency of CD8 escape mutations in elite controllers as new obstacle for HIV cure.
    Navarrete-Muñoz MA; Ramos R; Holguín Á; Cabello A; Górgolas M; Benito JM; Rallón N
    Virulence; 2022 Dec; 13(1):1713-1719. PubMed ID: 36190143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.
    Chopera DR; Woodman Z; Mlisana K; Mlotshwa M; Martin DP; Seoighe C; Treurnicht F; de Rosa DA; Hide W; Karim SA; Gray CM; Williamson C;
    PLoS Pathog; 2008 Mar; 4(3):e1000033. PubMed ID: 18369479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
    Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
    J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.